Connect with us

Hi, what are you looking for?

Jewish Business News


Varonis Data security Company plans $150 million NY IPO

The company has chosen underwriters for the offering, which may be held before the end of 2013 at a company value of $500 million.

/ By Ilan Shavit / 

Big data company Varonis Inc. is planning to raise $100-150 million at a company value of $500 million in a Wall Street IPO, says Globes. The company has chosen the underwriters for the offering, which may be held before the end of this year.

Varonis Systems founded in 2005 by president and CEO Yaki Faitelson and CTO Ohad Korkus. Varonis is an innovator and solution provider of comprehensive, actionable data governance solutions for enterprises. The company’s installations span leading firms in the filedes f energy, manufacturing, health care, financial services and technology worldwide. The company patent-pending technology gives organizations total visibility and control over their data, ensuring access to  sensitive information only to authorized workers, and prevent its unauthorized distribution.

Varonis headquartered is in New York City, and its development center in Herzliya, Israel.

Varonis has raised $30 million over the years, from Evergreen Venture Partners, Pitango Venture Capital , Accel Partners, and secured a strategic investment from EMC Corporation (NYSE: EMC). The low investment means that the investors and entrepreneurs will make a respectable return on the exit.

Varonis was in acquisition talks a year ago with IBM Corporation (NYSE: IBM) at a company value of $450 million. Although no deal was reached, no one will be surprised if Varonis, like other companies in its field, ultimately ends up as part of IBM or other computer giant.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.

cialis cialis satış